Chewy stock price target raised to $48 from $39 at JMP Securities

JMP Securities raised its price target on Chewy (CHWY) to $48, maintaining an Outperform rating, citing the substantial U.S. pet spending market, Chewy's revenue visibility from its autoship program, and potential for margin expansion. This bullish sentiment coincides with the company's largest shareholder announcing a $1 billion secondary offering, from which Chewy will not receive proceeds, though the company plans a separate $100 million stock repurchase. While JMP and Citizens JMP are optimistic about Chewy's growth prospects, other firms like UBS and Needham maintain more cautious ratings due to concerns over profitability trajectory and valuation, presenting a mixed analyst outlook despite Chewy's strong market position.

Analysis

Chewy, Inc. (CHWY) presents a bifurcated analyst outlook, anchored by a bullish price target upgrade from JMP Securities to $48.00, which cites the expansive $152 billion U.S. pet spending market and the durable "pet humanization" trend as fundamental tailwinds. JMP's confidence is rooted in Chewy's $12.1 billion in last-twelve-months revenue, a solid 29.24% gross profit margin, and the recurring revenue visibility provided by its autoship program. The firm specifically identifies advertising as a key lever for margin expansion. However, this optimism is tempered by more cautious views from UBS, which flags concerns over the company's profitability trajectory, and Needham, which maintains a Hold rating due to valuation. This mixed sentiment coincides with a significant capital markets event: a $1 billion secondary stock offering by Chewy's largest shareholder. Critically, Chewy will not receive proceeds, positioning the event as a liquidity move for the shareholder rather than a capital raise by the company. Mitigating potential stock pressure from this sale, Chewy has announced a concurrent $100 million share repurchase, which is additive to its existing $500 million buyback program, signaling management's confidence in the face of the large-scale shareholder exit.

Key Decisions for Investors

• Investors should weigh the bullish growth thesis from JMP, focused on margin expansion and a large addressable market, against the valuation and profitability concerns raised by other analysts like UBS and Needham.
• Consider the potential for near-term share price volatility due to the $1 billion secondary offering, which increases the available float, but note the mitigating effect of the company's new $100 million stock repurchase plan.
• Monitor future earnings reports for evidence of EBITDA growth outpacing revenue, as anticipated by Citizens JMP, which would validate the bull case for margin expansion through the advertising and health segments.